Thrombosis after liver transplantation for hepatocellular carcinoma.
The influence of thrombosis on the prognosis of patients with hepatocellular carcinoma (HCC) after liver transplantation (LT) and the role of the commonest inherited thrombophilia abnormalities factor V Leiden and prothrombin G20210A in the development of thrombosis are unknown. We investigated a co...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC5658078?pdf=render |
| _version_ | 1811321302767632384 |
|---|---|
| author | Ida Martinelli Francesca R Ponziani Alberto Maino Sherrie Bhoori Maria Abbattista Umberto Maggi Tullia M De Feo Paolo Bucciarelli Andrea Artoni Elena Longhi Marta Serafini Giorgio Rossi Vincenzo Mazzaferro |
| author_facet | Ida Martinelli Francesca R Ponziani Alberto Maino Sherrie Bhoori Maria Abbattista Umberto Maggi Tullia M De Feo Paolo Bucciarelli Andrea Artoni Elena Longhi Marta Serafini Giorgio Rossi Vincenzo Mazzaferro |
| author_sort | Ida Martinelli |
| collection | DOAJ |
| description | The influence of thrombosis on the prognosis of patients with hepatocellular carcinoma (HCC) after liver transplantation (LT) and the role of the commonest inherited thrombophilia abnormalities factor V Leiden and prothrombin G20210A in the development of thrombosis are unknown. We investigated a cohort of patients who underwent LT for HCC with the aim to estimate the incidence rate (IR) of thrombosis, its influence on mortality and re-transplantation rates and, in the frame of a nested case-control study, the role of thrombophilia in donors and recipients for the development of thrombosis. Four-hundred and thirty patients underwent LT and were followed for a median of 7.2 years. Twenty-six recipients (6%) developed thrombosis (IR 1.06 [95%CI: 0.71-1.53] per 100 pts-yr). Mortality rate after LT was 3.95 (95%CI: 3.22-4.79) per 100 pts-yr and was not influenced by thrombosis. Re-transplantation was planned for 33 patients and was more common in patients with thrombosis than in those without (HR 2.50 [95%CI: 0.87-7.17]). The risk of thrombosis was 4 times higher in recipients with thrombophilia than in those without (OR 4.23 [95%CI: 0.99-18.04]) and 6 times higher when the analysis was restricted to venous thrombosis (OR 6.26 [95%CI: 1.19-32.85]). The presence of inherited thrombophilia in the donors did not increase the risk of thrombosis of the recipient. In conclusion, thrombosis is a complication of 6% of patients transplanted for HCC and increases the risk of re-transplantation but not of mortality. The risk of thrombosis, particularly venous, is increased in the presence of thrombophilia abnormalities in the recipients. |
| first_indexed | 2024-04-13T13:15:39Z |
| format | Article |
| id | doaj.art-d0e35e32ae304101a13397bcec691df2 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-04-13T13:15:39Z |
| publishDate | 2017-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-d0e35e32ae304101a13397bcec691df22022-12-22T02:45:30ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-011210e018669910.1371/journal.pone.0186699Thrombosis after liver transplantation for hepatocellular carcinoma.Ida MartinelliFrancesca R PonzianiAlberto MainoSherrie BhooriMaria AbbattistaUmberto MaggiTullia M De FeoPaolo BucciarelliAndrea ArtoniElena LonghiMarta SerafiniGiorgio RossiVincenzo MazzaferroThe influence of thrombosis on the prognosis of patients with hepatocellular carcinoma (HCC) after liver transplantation (LT) and the role of the commonest inherited thrombophilia abnormalities factor V Leiden and prothrombin G20210A in the development of thrombosis are unknown. We investigated a cohort of patients who underwent LT for HCC with the aim to estimate the incidence rate (IR) of thrombosis, its influence on mortality and re-transplantation rates and, in the frame of a nested case-control study, the role of thrombophilia in donors and recipients for the development of thrombosis. Four-hundred and thirty patients underwent LT and were followed for a median of 7.2 years. Twenty-six recipients (6%) developed thrombosis (IR 1.06 [95%CI: 0.71-1.53] per 100 pts-yr). Mortality rate after LT was 3.95 (95%CI: 3.22-4.79) per 100 pts-yr and was not influenced by thrombosis. Re-transplantation was planned for 33 patients and was more common in patients with thrombosis than in those without (HR 2.50 [95%CI: 0.87-7.17]). The risk of thrombosis was 4 times higher in recipients with thrombophilia than in those without (OR 4.23 [95%CI: 0.99-18.04]) and 6 times higher when the analysis was restricted to venous thrombosis (OR 6.26 [95%CI: 1.19-32.85]). The presence of inherited thrombophilia in the donors did not increase the risk of thrombosis of the recipient. In conclusion, thrombosis is a complication of 6% of patients transplanted for HCC and increases the risk of re-transplantation but not of mortality. The risk of thrombosis, particularly venous, is increased in the presence of thrombophilia abnormalities in the recipients.http://europepmc.org/articles/PMC5658078?pdf=render |
| spellingShingle | Ida Martinelli Francesca R Ponziani Alberto Maino Sherrie Bhoori Maria Abbattista Umberto Maggi Tullia M De Feo Paolo Bucciarelli Andrea Artoni Elena Longhi Marta Serafini Giorgio Rossi Vincenzo Mazzaferro Thrombosis after liver transplantation for hepatocellular carcinoma. PLoS ONE |
| title | Thrombosis after liver transplantation for hepatocellular carcinoma. |
| title_full | Thrombosis after liver transplantation for hepatocellular carcinoma. |
| title_fullStr | Thrombosis after liver transplantation for hepatocellular carcinoma. |
| title_full_unstemmed | Thrombosis after liver transplantation for hepatocellular carcinoma. |
| title_short | Thrombosis after liver transplantation for hepatocellular carcinoma. |
| title_sort | thrombosis after liver transplantation for hepatocellular carcinoma |
| url | http://europepmc.org/articles/PMC5658078?pdf=render |
| work_keys_str_mv | AT idamartinelli thrombosisafterlivertransplantationforhepatocellularcarcinoma AT francescarponziani thrombosisafterlivertransplantationforhepatocellularcarcinoma AT albertomaino thrombosisafterlivertransplantationforhepatocellularcarcinoma AT sherriebhoori thrombosisafterlivertransplantationforhepatocellularcarcinoma AT mariaabbattista thrombosisafterlivertransplantationforhepatocellularcarcinoma AT umbertomaggi thrombosisafterlivertransplantationforhepatocellularcarcinoma AT tulliamdefeo thrombosisafterlivertransplantationforhepatocellularcarcinoma AT paolobucciarelli thrombosisafterlivertransplantationforhepatocellularcarcinoma AT andreaartoni thrombosisafterlivertransplantationforhepatocellularcarcinoma AT elenalonghi thrombosisafterlivertransplantationforhepatocellularcarcinoma AT martaserafini thrombosisafterlivertransplantationforhepatocellularcarcinoma AT giorgiorossi thrombosisafterlivertransplantationforhepatocellularcarcinoma AT vincenzomazzaferro thrombosisafterlivertransplantationforhepatocellularcarcinoma |